US equities
|
TSLA
$394.42
▲+5.96%
MU
$906.32
▲+3.28%
SPCX
$149.25
▲+1.19%
NVDA
$215.37
▲+2.09%
META
$641.30
▼-0.21%
SNDK
$1,262.80
▲+2.00%
AAPL
$344.67
▼-0.88%
INTC
$90.67
▲+4.26%
TSLA
$394.42
▲+5.96%
MU
$906.32
▲+3.28%
SPCX
$149.25
▲+1.19%
NVDA
$215.37
▲+2.09%
META
$641.30
▼-0.21%
SNDK
$1,262.80
▲+2.00%
AAPL
$344.67
▼-0.88%
INTC
$90.67
▲+4.26%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
NeuroOne Medical Technologies Corporation - Common Stock
(NQ:
NMTC
)
0.8390
-0.0810 (-8.80%)
Delayed Quote
Updated: 12:04 PM EDT, Oct 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about NeuroOne Medical Technologies Corporation - Common Stock
< Previous
1
2
3
Next >
NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED™ Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research Program
October 22, 2026
From
NeuroOne Medical Technologies Corporation
Via
GlobeNewswire
NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology
October 08, 2026
From
NeuroOne Medical Technologies Corporation
Via
GlobeNewswire
NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order
October 05, 2026
From
NeuroOne Medical Technologies Corporation
Via
GlobeNewswire
NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement
September 17, 2026
Agreement Covers Key Southern California Counties Including Los Angeles Metro as NeuroOne Broadens Commercial Access in Key U.S. Markets
From
NeuroOne Medical Technologies Corporation
Via
GlobeNewswire
BioMedNewsBreaks — NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) Completes Three Large-Animal Procedures Using StereoCED(TM) Platform
August 27, 2026
Via
Investor Brand Network
NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED(TM) Platform
August 27, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9%
August 13, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Supply Chain
NeuroOne(R) Achieves Major Milestone With ISO 13485 Certification
August 11, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time
August 03, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Earnings
NeuroOne Releases CNS Drug Delivery White Paper Ahead of Planned Fiscal Year-End Availability of the StereoCED(TM) Platform
July 30, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based on Reports by Physicians
July 28, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial
July 16, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
NeuroOne(R) Added to Russell Microcap(R) Index
June 29, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
NeuroOne(R) Added to Russell Microcap(R) Index
June 29, 2026
EDEN PRAIRIE, MINN. - June 29, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the...
Via
TheNewswire.com
NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 25, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 25, 2026
EDEN PRAIRIE, MINN. - June 25, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the...
Via
TheNewswire.com
NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index
June 16, 2026
EDEN PRAIRIE, MINN. - June 16, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the...
Via
TheNewswire.com
NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index
June 16, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time
June 08, 2026
EDEN PRAIRIE, MINN., - June 8, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the...
Via
TheNewswire.com
NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time
June 08, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026
May 28, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026
May 28, 2026
EDEN PRAIRIE, MINN. - May 28, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the...
Via
TheNewswire.com
NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026
May 22, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026
May 22, 2026
Ongoing Business Not Affected, Company Reaffirms Product Revenue Guidance of at Least $10.5 Million for Fiscal Year 2026
Via
TheNewswire.com
NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update
May 12, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Economy
NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update
May 12, 2026
Product Revenue of $2.4 Million up 72% Year Over Year
Via
TheNewswire.com
Topics
Economy
NeuroOne(R) Regains Compliance With Nasdaq Listing Requirement
May 04, 2026
EDEN PRAIRIE, MINN. - May 4, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the...
Via
TheNewswire.com
NeuroOne(R) Regains Compliance With Nasdaq Listing Requirement
May 04, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
NeuroOne(R) Announces Chief Financial Officer Succession Plan
April 30, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Retirement
NeuroOne(R) Announces Chief Financial Officer Succession Plan
April 30, 2026
Ron McClurg to Retire as CFO Effective June 30 and Remain as Senior Advisor Through December 31 to Support Transition
Via
TheNewswire.com
Topics
Retirement
< Previous
1
2
3
Next >
